Are you also looking for information about which stock to look at in China Shipping Medical Health Industry? That's right. Bian Xiao has carefully compiled this article about which stock to look at in China Shipping Medical Health Industry, which should be able to answer your doubts. For more information about which stock to look at in China Shipping Medical Health Industry, you can search in the upper right corner.
Which stock does China Shipping Medical Health Industry look at?
At present, there are two stocks involved in the health industry of China Shipping Medicine:
_ _ Baiyunshan (600332): Baiyunshan is a listed company under Guangzhou Pharmaceutical Group, which is the first enterprise in China to obtain the drug clinical trial license from a new drug research and development institution.
_ _ China Pharmaceutical (600056): The company is one of the core platforms of medical and health industry in China, mainly engaged in chemical drugs, domestic pharmaceutical circulation business and derivative business.
It is suggested that you decide your investment strategy according to your investment objectives, risk tolerance and market conditions. The above stock appraisal results are for reference only, and specific investment decisions need to be made according to professional investment advice and industry analysis.
Stock analysis of China Shipping Medicine
China Shipping Medicine (0 1202. HK) is a company mainly engaged in pharmaceutical manufacturing. Recently, the company announced its 2022 financial report, with annual operating income of 654.38+37 billion yuan, up 5.95% year-on-year. However, the net profit attributable to shareholders of listed companies was 29 1 100 million yuan, down 14.24% year-on-year. The company mentioned that this is because the Group implemented convertible bond share repurchase and cash dividend in 20021year, with a total amount of1470,000 yuan, and the exchange loss caused by exchange rate fluctuation in this period was 454 19000 yuan.
However, in terms of business segment, due to the company's continuous expansion of sales channels of its own brand products during the reporting period, the operating income of pharmaceutical manufacturing business was 83 1 100 million yuan, up by 17.67% year-on-year, and the gross profit margin was 63.05%, up by 4.78 percentage points over the same period of last year. This reflects the improvement of the company's main business.
As for the trend of the pharmaceutical sector of Hong Kong stocks, as of April 9, 2023, the average decline of this sector in the past year was 14%, reflecting that the situation of the whole industry may be unstable. But at the same time, if we subtract the industry average decline from cosl's share price, we will find that cosl's share price trend outperforms the broader market (3.73%), which may have a positive impact on the company's investment value.
To sum up, although cosl's financial performance in 2022 is worse than expected, the improvement of its business segments and relatively strong market performance may make investors optimistic about its future development.
What is the share price of China Shipping Medicine?
The stock code of CNOOC Pharmaceutical is 00 1224, and the current share price is 14.6438+00. As far as I know, CNOOC Medicine is an innovative medical and health industry group integrating medical research and development, pharmaceutical industry, pharmaceutical business and medical health. The highlight of the company is that it has the leading research and development capabilities of chemical drugs, biological drugs and traditional Chinese medicines in China, and has the whole process of drug research and development from innovative drug research, pharmaceutical research, clinical trials to market sales.
In addition, the pharmaceutical dosage forms of China Shipping Medicine are mainly oral solid preparations, including large-capacity injection, freeze-dried powder injection, inhalation solution and raw material medicine mixture. The three dominant clinical departments are cardiovascular medicine, orthopedics and neurology, and there are dozens of exclusive agents in China. Commercial retail terminals cover 2.57 million retail pharmacies and 6.5438+0.3 million retail clinics nationwide. The company's pharmaceutical wholesale business covers 29 provinces, autonomous regions and municipalities directly under the Central Government. The number of cooperative hospitals exceeds 3,654.38+million, and the annual terminal sales exceed 40 billion yuan.
To sum up, CNOOC Medicine is a competitive company in the medical and health industry. For the company's stock market, you need to pay more attention to market dynamics and company announcements.
China Shipping Pharmaceutical Mixed Stock
China Shipping Pharmaceutical Hybrid Stock Securities Investment Fund is a hybrid fund wealth management product issued by China Shipping Fund.
Investment objectives of the Fund: The Fund mainly invests in pharmaceutical biology, health industry and high-quality non-pharmaceutical stocks related to health. Through asset allocation and flexible use of various investment strategies, we can grasp capital appreciation and relatively stable cash income and realize long-term stable appreciation of fund assets.
What stocks does the hybrid fund of China Shipping Medicine contain?
China Shipping Pharmaceutical Mixed Fund has _ _ _ _ _ _1_ _ _ _ _ _ *, and this 1 1 fund * * * has a _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _.
These funds mainly invest in stocks of pharmaceutical biology, medical devices, medical services, chemical pharmaceuticals, medical devices and other industries, and also invest in stocks of some non-pharmaceutical companies. The performance benchmark of these funds is _ _ 70% of the yield of CSI medical and health industry index+_ 20% of the total yield of China Bond Index (full price)+10% of RMB deposit interest rate of financial institutions (after tax).
Please note that investment is risky, and the specific investment strategy may be different due to the specific situation of the fund. Before making an investment decision, it is recommended that you carefully read the prospectus and fund contract of the relevant fund.
This is the end of the introduction of China Shipping Medicine Health Industry Stock.